Home › Tricuspid Valve Insufficiency › Minnesota
Tricuspid Valve Insufficiency clinical trials in Minnesota
8 studies for Tricuspid Valve Insufficiency are looking for participants at sites in Minnesota.
Cities in Minnesota
EFS of the DUO System for Tricuspid Regurgitation
- Allina Health Minneapolis Heart Institute Foundation, Minneapolis
Recruiting
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05913908Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
- Mayo Clinic, Rochester
Recruiting
Ages 18 to 90 · All sexes · Updated Sep 25, 2026 · NCT06183684Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
- Abbott Northwestern Hospital, Minneapolis
Recruiting
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07321899Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
- Mayo Clinic - Rochester, Rochester
Recruiting
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05848284Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
- Mayo Clinic, Rochester
Recruiting
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT04097145VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
- Minneapolis Heart Institute Foundation, Minneapolis
Recruiting
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT07516444The TRICURE EFS Study
- Minneapolis Heart Institute Foundation, Minneapolis
Recruiting
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT06506942Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
- Mayo Clinic Hospital (Rochester), Rochester
Recruiting
Ages 18 to 85 · All sexes · Updated Mar 7, 2025 · NCT06212193From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.